News and Events
The University of Michigan Health System (UMHS) and the Peking University Health Science Center (PUHSC) Joint Institute for Translational and Clinical Research is accepting joint proposals from investigators working collaboratively at both institutions for funding of projects that will demonstrate an effective team approach to discovery and new findings on diseases relative to both countries, and which can be leveraged for extramural funding opportunities. Full RFP is available here.
This edition of the newsletter provides an overview and highlights from the Sixth Annual JI Symposium. While individual collaborators worked to move forward current projects and create new ones, leaders from PUHSC and UMMS met to discuss future JI strategies to ensure continued growth and success.
You will also find updates from each of the primary JI project areas: Renal, Pulmonary, Liver/GI and Cardiovascular. Beyond that, our work in the JI continues to expand into other areas of medicine. To that end, we recap several meetings that took place during the Symposium week between PUHSC and UMMS leaders in Nursing, Pharmacy and other areas of potential collaboration. Finally, we touch base with several of our PUHSC visitors to talk about their experience at UMMS. As you’ll see, we have much to celebrate and even more to look forward to as 2017 gets under way. Read the December2016 Newsletter here.
Good science transcends culture, language and distance, as it did last week during an annual symposium that attracted a large group of China’s top physician scientists to UMHS.
Faculty members from China’s Peking University Health Science Center, the country’s premier medical school and research institution, joined UMHS colleagues and collaborators in Ann Arbor for the Symposium of the Joint Institute (JI) for Translational and Clinical Research. In all, 75 PUHSC faculty members made the 14-hour journey from Beijing, the largest single delegation of visiting scholars ever hosted by the U-M Medical School.
“It is unusual to have people from such different cultures, with different languages, different approaches, and different ways of working, to partner with each other. What we are doing together is remarkable,” said Joseph C. Kolars, the Josiah Macy, Jr. Professor of Health Professions Education and Senior Associate Dean for Education and Global Initiatives.
The annual meeting is organized through Global REACH, which oversees many of medical school’s international partnerships. In six short years since its launch, the UMHS-PUHSC JI has grown to include more than 30 ongoing research projects, each led by a PI from both institutions, across a number of fields, including liver, pulmonary, renal, cardiovascular and other diseases. This year’s symposium, which took place Oct. 12-14, featured keynote speeches from PUHSC President Qimin Zhan and UMHS Executive Vice President of Medical Affairs and U-M Medical School Dean Marschall Runge, M.D., Ph.D.
“With the Joint Institute, there are many opportunities to leverage our strengths when you take both of these great institutions together,” said Runge. “I know that we have complimentary research strengths and a unique potential for discovery.”
Among the Chinese doctors who traveled to Ann Arbor for the event was Yuwu Jiang, M.D., Ph.D. A pediatrician at PUHSC, Dr. Jiang is partnering with U-M Pharmacology Professor Lori Isom, Ph.D., on a joint study to better understand genetic causes of epilepsy in children. The two met at an international pediatrics conference last year and began planning their joint research project, among eight new studies to be funded this year through the JI. The opportunity to meet again in person at the symposium will accelerate their work, Jiang said.
“This was my first opportunity to visit Lori’s lab, meet her team and see how it runs,” he said. “You have to meet face to face to be able to understand one another more precisely. Collaborating always just by telephone or email isn’t enough.”
In addition to the scientific expertise, among the major benefits of partnering with PUHSC is sheer size of the system. The center is affiliated with more than a dozen hospitals in the Beijing area.
“The population there is a huge resource. If you study a relatively uncommon disease here, you may have five patients to study. There, they have 500,” said Dr. Eugene Chen, U-M Frederick Huetwell Professor of Cardiovascular Medicine and a co-leader of the JI’s extensive cardiovascular disease program. “In addition, each side brings different expertise and experience, so we can learn a lot from each other. This meeting is an opportunity not only for existing partners to get together, but also for people to meet new partners.”
The Symposium took place primarily at the Rackham School for Graduate Studies, but also included hospital and medical campus tours, as well as satellite meetings at the North Campus Research Center, among other places. There were individual partner meetings, group meetings around distinct illness areas and panel discussions. Next year’s meeting will be in Beijing.
“This is an important partnership, and we enjoyed every second of our visit to Ann Arbor,” PUHSC President Qimin Zhan said at the close of the final session. “We look forward to hosting an even larger delegation next year.”
Click here to read more about the Joint Institute and the sixth annual JI Symposium.
JI partnerships aren’t just about faculty; students and physicians-in-training benefit, too. Read about a U-M resident’s influential rotation with PUHSC, as well as several medical students who are now published authors after working in China under JI mentors.
Indeed, we have much to celebrate. Our institutional relationship continues to thrive to the benefit of our colleagues and students, to say nothing of the many future discoveries that will no doubt improve healthcare for people everywhere. Please enjoy this issue and we look forward to seeing many of you at this year’s JI Symposium. Read the September 2016 Newsletter here.
Several medical students are now published authors following the completion of international research projects under the guidance of Hepatology Professor and longtime student mentor Anna Suk-Fong Lok, MD.
Dr. Lok’s projects explored aspects of liver disease treatment and care and included extensive on-the-ground research in China. The resulting publications, in recent issues of Digestive Diseases & Sciences and Liver International, garnered author credits for four U-M Medical School students: Fanny Du, Jiaxin Huang, Mary Guan, and Jeremy Balch.
In addition to the four UMMS students, three undergraduate students, Angela Xie, Shanna Cheng and Cassandra Rodd, also contributed to the projects and are credited co-authors.
Fourth-year University of Michigan Medical School student Fanny Du visited in China the summer of 2014 on a Global REACH scholarship. She and Angela Xi surveyed hundreds of patients seen in liver disease clinics about their care experience. Those results were compared against data from patients seen in Ann Arbor liver clinics. The findings, A Comparative Study of Liver Disease Care in the USA and Urban and Rural China, have been published online ahead of print in Digestive Diseases and Sciences.
“My goal is to work with immigrant populations, so understanding the differences in the healthcare systems in the US and elsewhere will make me a better physician,” Ms. Du said. “The differences we saw were eye opening. The clinics in Beijing are crowded. People don’t make appointments and so they might wait for hours to see a doctor for five minutes. I could see why patients might be less satisfied with their care there (compared to patients in Ann Arbor), which is exactly what we found.”
A second study, Survey of Hepatitis B Knowledge and Stigma among Chronically Infected Patients and Uninfected Persons in Beijing, has also been published online ahead of print in Liver International. Third-year medical student Jiaxin Huang, along with fellow students Jeremy Balch and Mary Guan, spent several weeks in Beijing in the summer of 2015 interviewing more than 1,200 people to study stigma around hepatitis B, a prevalent disease in China. Global REACH supported their international experiences as well.
“Given our findings, we believe that public health education can improve understanding of transmission of hepatitis B and alleviate stigma towards the patients,” Ms. Huang said. “Furthermore, physicians can also actively counsel patients to reduce internal stigma. It was very satisfying to have this research published because we felt our results were important in that they revealed and quantified the stigma hepatitis B patients face every day.”
In addition to the publication, their project garnered a poster presentation at the 2015 Asian Pacific American Medical Student Association conference and an oral presentation, delivered by Ms. Huang, during the 2016 Digestive Disease Week conference held in San Diego in May.
“I mentor a lot of students, but this was the first time a student of mine was selected for an oral presentation at such a big meeting,” said Dr. Lok. “Jiaxin was speaking to a group of distinguished board-certified gastroenterologists who’ve been practicing for years or decades. You can imagine that it’s nerve wracking, but she did very well. I felt like a proud parent.”
Dr. Michael Fetters won’t be attending this year’s Joint Institute Symposium in Ann Arbor.
But he has a good excuse.
This October will find the U-M Professor of Family Medicine in China midway through a Fulbright research project, the roots of which can be traced back to the 2014 Symposium and an encounter with a Peking University Health Science Center (PUHSC) colleague, Dr. Yali Cong.
“I had been thinking about submitting a Fulbright proposal for a while, but attending the Symposium and meeting Dr. Cong helped me crystalize my idea for the proposal,” said Dr. Fetters. “I realized that we shared a common interest in the way different cultures approach medical decision making.”
Dr. Cong is Dean of PUHSC’s Department of Medical Humanities and a professor of medical ethics. She and Dr. Fetters developed a plan to examine Chinese physicians’ attitudes about approaches to disclosing cancer and cancer decision making. The proposal garnered Dr. Fetters a 2016 Fulbright Distinguished Chair award in Social Sciences, one of Fulbright’s most prestigious honors. Beginning late summer, he will spend five months at PUHSC, teaching a mixed-methods research course and working with Dr. Cong on their joint research project.
“If I’d not attended the Symposium, it’s fair to say that the proposal would’ve been much, much different,” Dr. Fetters said. “You never know who you will meet at these events and what ideas it might spark.”
This year marks the sixth annual U-M PUHSC JI Symposium, an opportunity for current partners to showcase their research to JI colleagues, as well as a chance to meet new collaborators for future projects. The event takes place Oct. 12-14 in Ann Arbor and registration is now open.
On this year’s schedule are keynote addresses from UMHS Executive Vice President for Medical Affairs Marschall Runge, MD, and PUHSC President Qi-Min Zhan, MD, as well as panel discussions, a poster presentation and more. Faculty members from medical school as well as other health-related schools are welcome to attend (e.g., Public Health, Pharmacy, Bioengineering, and Nursing).
The Joint Institute (JI) for Translational and Clinical Research is touted as a successful institutional partnership in a paper recently published in Academic Medicine.
The article, written by leaders of the JI and e-published ahead of a future print edition of the journal, highlights best practices, lessons and significant outcomes to emerge from the University of Michigan Health Systems’ partnership with Peking University Health Science Center. Detailed are the leadership and governance models for the partnership.
“Institution-level collaborative partnerships across cultures are not without their challenges … including differences in governance structures, funding mechanisms … and intellectual property laws,” write the paper’s eight authors, led by Dr. Joseph Kolars, MD, U-M Senior Associate Dean for Education and Global Initiatives. “One of the foundational aspects of the JI is that all decisions are made jointly … with a clear understanding that all decisions, including the dispersion of funds, will be agreed upon by both institutions.”
That approach, according the authors, has proven effective. Since established in 2010, the JI has funded 25 joint research projects involving more than 100,000 patients in both the U.S. and China. Those projects have produced 13 peer-reviewed publications and counting. In addition to research funding provided through the JI by the partner universities, principal investigators in various projects have secured more than $3 million in extramural funding. The partnership appears on track for long-term sustainability.
“We are optimistic about the future of the JI because this model has been deemed valuable by the presidents of both institutions and has gained wide support among faculty,” the authors note. “We aim to position investigators to compete successfully for funding opportunities within China and the United States and to advance … our mutual understanding of health and diseases that affect the populations of both countries.”
View the abstract and download a full copy of the report here.